Oneness Biotech Co Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.41x

Oneness Biotech Co Ltd capital reinvestment ratio. Oneness Biotech Co Ltd (4743) has a Capital Reinvestment Ratio of 0.41x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$14.32 Million) in capital expenditures (NT$5.92 Million). Check cash flow reinvestment rate of Oneness Biotech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.41x
Capex / Operating Cash Flow

Operating Cash Flow

NT$14.32 Million
TWD

Capital Expenditures

NT$5.92 Million
TWD

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Oneness Biotech Co Ltd (2010–2020)

Capital reinvestment ratio of Oneness Biotech Co Ltd from 2010 to 2020. This chart tracks Oneness Biotech Co Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore net asset growth rate of Oneness Biotech Co Ltd to track the company's year-over-year net asset growth rate.

Oneness Biotech Co Ltd Capital Reinvestment Ratio by Year (2010–2020)

Oneness Biotech Co Ltd capital reinvestment ratio by year from 2010 to 2020. For the full cash flow conversion analysis, see 4743 cash generation efficiency.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2020 0.97x NT$158.14 Million NT$153.27 Million ▲ +151.7%
2012 0.39x NT$24.15 Million NT$9.30 Million ▲ +286.2%
2010 0.10x NT$153.25 Million NT$15.28 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow